Personal information

Activities

Employment (3)

University Hospital Frankfurt: Frankfurt am Main, Hessen, DE

2018-05-01 to present (Dr. Senckenberg. Institute of Pathology)
Employment
Source: Self-asserted source
Paul Ziegler

Georg-Speyer-Haus: Frankfurt am Main, DE

2014-07-01 to 2018-04-30 (Institute of Tumor Biology and Experimental Therapy)
Employment
Source: Self-asserted source
Paul Ziegler

Technical University of Munich: Munich, Bavaria, DE

2010-04-01 to 2014-06-30 (Institute of Molecular Immunology)
Employment
Source: Self-asserted source
Paul Ziegler

Education and qualifications (2)

Technical University of Munich: Munich, DE

2019-04-15 to present | Philosophical Doctor (Medical Faculty)
Education
Source: Self-asserted source
Paul Ziegler

Technical University of Munich: Munich, DE

2014-09-01 to present | Medical License (Medical Faculty)
Education
Source: Self-asserted source
Paul Ziegler

Works (14)

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer.

Cancer cell
2022-02-03 | Journal article
Source: Self-asserted source
Paul Ziegler

Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2022-01-06 | Journal article
Source: Self-asserted source
Paul Ziegler

Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer.

The oncologist
2021-10-06 | Journal article
Source: Self-asserted source
Paul Ziegler

AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer.

The Journal of experimental medicine
2020-10-01 | Journal article
Source: Self-asserted source
Paul Ziegler

Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis.

Oncogene
2018-10-23 | Journal article
Source: Self-asserted source
Paul Ziegler

Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.

Cell
2018-06-14 | Journal article
Source: Self-asserted source
Paul Ziegler

Übersicht – Zelluläre und molekulare Grundlagen des Kolonkarzinoms

TumorDiagnostik & Therapie
2015-12-08 | Journal article
Part of ISSN: 0722-219X
Part of ISSN: 1439-1279
Source: Self-asserted source
Paul Ziegler

IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis.

The Journal of experimental medicine
2015-11-30 | Journal article
Source: Self-asserted source
Paul Ziegler

High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.

Nature
2014-08-31 | Journal article
Source: Self-asserted source
Paul Ziegler

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

The Journal of clinical investigation
2014-03-18 | Journal article
Source: Self-asserted source
Paul Ziegler

Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.

Cancer cell
2013-08-01 | Journal article
Source: Self-asserted source
Paul Ziegler

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

Cell
2012-12-27 | Journal article
Source: Self-asserted source
Paul Ziegler

Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.

Cancer cell
2012-12-27 | Journal article
Source: Self-asserted source
Paul Ziegler

TNF-alpha-dependent loss of IKKbeta-deficient myeloid progenitors triggers a cytokine loop culminating in granulocytosis.

Proceedings of the National Academy of Sciences of the United States of America
2011-04-04 | Journal article
Source: Self-asserted source
Paul Ziegler